Secondary risks of bleeding and associated outcome after tirofiban application during interventional treatment of intracranial aneurysms.

Brain Spine · 2026 · PMC13314804 · PMID 42382654

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significancep = 0.06so close (0.05 < p ≤ 0.1)

This difference did not reach statistical significance for prolonged tirofiban versus no tirofiban (p = 0.06) or for short-term tirofiban versus no tirofiban (p = 0.25).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.